Skip to main content
Equibles

Mads Berndt

CFO

Hemab Therapeutics Holdings, Inc. (COAG)

Equibles does not estimate personal net worth.

Get an email with a short summary when Hemab Therapeutics Holdings, Inc. publishes a filing, an earnings call transcript or a press release.

Get COAG alerts

About Mads Berndt

Mads Berndt is recorded as CFO at Hemab Therapeutics Holdings, Inc. (COAG). Mads Berndt has spoken on 1 earnings call across 1 company, most recently for Hemab Therapeutics Holdings, Inc. on November 10, 2026. Hemab Therapeutics Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Hemab Therapeutics Holdings, Inc. includes Keli Walbert (Board Member).

Mads Berndt on recent calls

“Cash, cash equivalents, and marketable securities were $430.2 million as of September 30, compared with $457.5 million as of June 30. We continue to expect our cash to fund operations into 2029.”
CFO, Hemab Therapeutics Third Quarter 2026 Financial Results and Corporate Update ·

Affiliation history

Company network

Leadership on record at Hemab Therapeutics Holdings, Inc.

Recent activity